Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma JOURNAL OF CLINICAL ONCOLOGY Evens, A. M., Advani, R. H., Helenowski, I. B., Fanale, M., Smith, S. M., Jovanovic, B. D., Bociek, G. R., Klein, A. K., Winter, J. N., Gordon, L. I., Hamlin, P. A. 2018; 36 (30): 3015-+
View details for DOI 10.1200/JCO.2018.79.0139
View details for Web of Science ID 000447725000007